SLC6A14 and cystic fibrosis: Finally, in relation to CF, a study using HEK-293 cells over-expressing SLC6A14 showed that SLC6A14 protein expression was reduced by suprapharmacological concentrations of Vx-770, a CFTR potentiator [40].